...
drug-img

Bright Minds Biosciences Inc, Common Stock

DRUG

NAQ

$41.4

+$1.65

(4.15%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$275.39M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
34.99K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.13
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.93 L
$79.02 H
$41.4

About Bright Minds Biosciences Inc, Common Stock

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameDRUGSectorS&P500
1-Week Return6.4%-3.39%0.2%
1-Month Return9.11%-1.92%2.72%
3-Month Return2981.4%-10.54%7.31%
6-Month Return3759.22%-4.47%10.44%
1-Year Return2567.79%4.06%27.53%
3-Year Return138.74%0.94%30.88%
5-Year Return47.22%36.67%89.21%

Financials

Sep '19Sep '20Sep '21Sep '22Sep '235YR TREND
Total Revenue-----[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Cost of Revenue---6.04K72.45K[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":8.33,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Gross Profit---(6.04K)(72.45K)[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":-603700,"profit":false},{"date":"2023-09-30","value":-7245000,"profit":false}]
Gross Margin-----[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Operating Expenses78.72K469.36K8.60M14.73M7.21M[{"date":"2019-09-30","value":0.53,"profit":true},{"date":"2020-09-30","value":3.19,"profit":true},{"date":"2021-09-30","value":58.41,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":48.97,"profit":true}]
Operating Income(78.72K)(469.36K)(8.76M)(14.74M)(7.21M)[{"date":"2019-09-30","value":-7872000,"profit":false},{"date":"2020-09-30","value":-46935800,"profit":false},{"date":"2021-09-30","value":-875855300,"profit":false},{"date":"2022-09-30","value":-1474216400,"profit":false},{"date":"2023-09-30","value":-721493300,"profit":false}]
Total Non-Operating Income/Expense-(16.59K)89.13K(232.93K)(157.29K)[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":-18.61,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-261.35,"profit":false},{"date":"2023-09-30","value":-176.48,"profit":false}]
Pre-Tax Income(78.72K)(480.38K)(8.65M)(14.96M)(7.37M)[{"date":"2019-09-30","value":-7871700,"profit":false},{"date":"2020-09-30","value":-48037700,"profit":false},{"date":"2021-09-30","value":-865076300,"profit":false},{"date":"2022-09-30","value":-1496494100,"profit":false},{"date":"2023-09-30","value":-737222500,"profit":false}]
Income Taxes(236.15)5.57K(135.43K)222.78K(14.19K)[{"date":"2019-09-30","value":-0.11,"profit":false},{"date":"2020-09-30","value":2.5,"profit":true},{"date":"2021-09-30","value":-60.79,"profit":false},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":-6.37,"profit":false}]
Income After Taxes-(485.94K)(8.52M)(15.19M)(7.36M)[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":-48594500,"profit":false},{"date":"2021-09-30","value":-851532900,"profit":false},{"date":"2022-09-30","value":-1518771800,"profit":false},{"date":"2023-09-30","value":-735803600,"profit":false}]
Income From Continuous Operations-(480.38K)(8.65M)(14.96M)(7.37M)[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":-48037700,"profit":false},{"date":"2021-09-30","value":-865076300,"profit":false},{"date":"2022-09-30","value":-1496494100,"profit":false},{"date":"2023-09-30","value":-737222500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Net Income(78.72K)(485.94K)(8.52M)(15.19M)(7.37M)[{"date":"2019-09-30","value":-7871700,"profit":false},{"date":"2020-09-30","value":-48594500,"profit":false},{"date":"2021-09-30","value":-851532900,"profit":false},{"date":"2022-09-30","value":-1518771800,"profit":false},{"date":"2023-09-30","value":-737222500,"profit":false}]
EPS (Diluted)--(0.61)(0.94)(0.77)[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":-61.05,"profit":false},{"date":"2022-09-30","value":-94.37,"profit":false},{"date":"2023-09-30","value":-76.59,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DRUG
Cash Ratio 34.65
Current Ratio 35.08
Quick Ratio 35.17

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DRUG
ROA (LTM) -28.86%
ROE (LTM) -51.80%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DRUG
Debt Ratio Lower is generally better. Negative is bad. 0.03
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.97

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DRUG
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 64.71
Price/FCF 1147
EV/R 0.00
EV/Ebitda NM

FAQs

What is Bright Minds Biosciences Inc share price today?

Bright Minds Biosciences Inc (DRUG) share price today is $41.4

Can Indians buy Bright Minds Biosciences Inc shares?

Yes, Indians can buy shares of Bright Minds Biosciences Inc (DRUG) on Vested. To buy Bright Minds Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DRUG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bright Minds Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Bright Minds Biosciences Inc (DRUG) via the Vested app. You can start investing in Bright Minds Biosciences Inc (DRUG) with a minimum investment of $1.

How to invest in Bright Minds Biosciences Inc shares from India?

You can invest in shares of Bright Minds Biosciences Inc (DRUG) via Vested in three simple steps:

  • Click on Sign Up or Invest in DRUG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bright Minds Biosciences Inc shares
What is Bright Minds Biosciences Inc 52-week high and low stock price?

The 52-week high price of Bright Minds Biosciences Inc (DRUG) is $79.02. The 52-week low price of Bright Minds Biosciences Inc (DRUG) is $0.93.

What is Bright Minds Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bright Minds Biosciences Inc (DRUG) is

What is Bright Minds Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bright Minds Biosciences Inc (DRUG) is 64.71

What is Bright Minds Biosciences Inc dividend yield?

The dividend yield of Bright Minds Biosciences Inc (DRUG) is 0.00%

What is the Market Cap of Bright Minds Biosciences Inc?

The market capitalization of Bright Minds Biosciences Inc (DRUG) is $275.39M

What is Bright Minds Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of Bright Minds Biosciences Inc is DRUG

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top